» Articles » PMID: 38554104

Magnetic Resonance Enterography and Intestinal Ultrasound for the Assessment and Monitoring of Crohn's Disease

Overview
Date 2024 Mar 30
PMID 38554104
Authors
Affiliations
Soon will be listed here.
Abstract

Magnetic resonance enterography [MRE] and intestinal ultrasound [IUS] have developed rapidly in the past few decades, emerging as the primary non-invasive options for both diagnosing and monitoring Crohn's disease [CD]. In this review, we evaluate the pertinent data relating to the use of MRE and IUS in CD. We summarise the key imaging features of CD activity, highlight their increasing role in both the clinical and the research settings, and discuss how these modalities fit within the diagnostic pathway. We discuss how they can be used to assess disease activity and treatment responsiveness, including the emergence of activity scores for standardised reporting. Additionally, we address areas of controversy such as the use of contrast agents, the role of diffusion-weighted imaging, and point-of-care ultrasound. We also highlight exciting new developments, including the applications of artificial intelligence. Finally, we provide suggestions for future research priorities.

Citing Articles

Comparison of volumetric and linear measurements of intestinal inflammation and treatment response in children with newly diagnosed ileal Crohn disease.

Derinkuyu B, Bard A, Naim I, Tkach J, Denson L, Dillman J Eur Radiol. 2025; .

PMID: 39934340 DOI: 10.1007/s00330-025-11421-7.


Advancing Therapeutic Targets in IBD: Emerging Goals and Precision Medicine Approaches.

Centanni L, Cicerone C, Fanizzi F, DAmico F, Furfaro F, Zilli A Pharmaceuticals (Basel). 2025; 18(1).

PMID: 39861141 PMC: 11768140. DOI: 10.3390/ph18010078.


Volumetric measurement of terminal ileal Crohn's disease by magnetic resonance enterography: a feasibility study.

Kumar S, Rao N, Bhagwanani A, Parry T, Hameed M, Rahman S Eur Radiol. 2024; 35(1):117-126.

PMID: 39028375 PMC: 11632055. DOI: 10.1007/s00330-024-10880-8.

References
1.
Chirra P, Sharma A, Bera K, Cohn H, Kurowski J, Amann K . Integrating Radiomics With Clinicoradiological Scoring Can Predict High-Risk Patients Who Need Surgery in Crohn's Disease: A Pilot Study. Inflamm Bowel Dis. 2022; 29(3):349-358. PMC: 9977224. DOI: 10.1093/ibd/izac211. View

2.
Maaser C, Sturm A, Vavricka S, Kucharzik T, Fiorino G, Annese V . ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 1: Initial diagnosis, monitoring of known IBD, detection of complications. J Crohns Colitis. 2018; 13(2):144-164. DOI: 10.1093/ecco-jcc/jjy113. View

3.
Liu R, Li H, Towbin A, Ata N, Smith E, Tkach J . Machine Learning Diagnosis of Small-Bowel Crohn Disease Using T2-Weighted MRI Radiomic and Clinical Data. AJR Am J Roentgenol. 2023; 222(1):e2329812. DOI: 10.2214/AJR.23.29812. View

4.
Tielbeek J, Ziech M, Li Z, Lavini C, Bipat S, Bemelman W . Evaluation of conventional, dynamic contrast enhanced and diffusion weighted MRI for quantitative Crohn's disease assessment with histopathology of surgical specimens. Eur Radiol. 2013; 24(3):619-29. DOI: 10.1007/s00330-013-3015-7. View

5.
Neurath M, Vieth M . Different levels of healing in inflammatory bowel diseases: mucosal, histological, transmural, barrier and complete healing. Gut. 2023; 72(11):2164-2183. DOI: 10.1136/gutjnl-2023-329964. View